Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C

Journal of Hepatology

Volumn 52, Issue 5, 2010, Pages 712-717

  Hov, Johannes R ^a,b   Lleo, Ana ^c,d   Selmi, Carlo ^c,d   Woldseth, Bente ^a   Fabris, Luca ^e,f   Strazzabosco, Mario ^g,h   Karlsen, Tom H ^a,b   Invernizzi, Pietro ^d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF MILAN   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h YALE UNIVERSITY   (United States)

Author keywords

HLA; Killer immunoglobulin like receptors; Natural killer cells; Primary sclerosing cholangitis

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; HLA C1 ANTIGEN; HLA DR ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; NATURAL KILLER CELL; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLANGITIS, SCLEROSING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; EUROPE; FEMALE; GENE FREQUENCY; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFLAMMATORY BOWEL DISEASES; ITALY; LIVER CIRRHOSIS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; YOUNG ADULT;

EID: 77951620945     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.11.029     Document Type: Article

References (46)

1. O'Mahony C.A., and Vierling J.M. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis 26 (2006) 3-21
2. Bergquist A., Montgomery S.M., Bahmanyar S., Olsson R., Danielsson A., Lindgren S., et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 6 (2008) 939-943
3. Karlsen T.H., Schrumpf E., and Boberg K.M. Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol 13 (2007) 5421-5431
4. Schrumpf E., Fausa O., Forre O., Dobloug J.H., Ritland S., and Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17 (1982) 187-191
5. Klein J., and Sato A. The HLA system. First of two parts. N Engl J Med 343 (2000) 702-709
6. Moloney M.M., Thomson L.J., Strettell M.J., Williams R., and Donaldson P.T. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 28 (1998) 660-662
7. Donaldson P.T., and Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35 (2002) 555-564
8. Wiencke K., Karlsen T.H., Boberg K.M., Thorsby E., Schrumpf E., Lie B.A., et al. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 69 (2007) 161-169
9. Spurkland A., Saarinen S., Boberg K.M., Mitchell S., Broome U., Caballeria L., et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53 (1999) 459-469
10. Leidenius M.H., Koskimies S.A., Kellokumpu I.H., and Hockerstedt K.A. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103 (1995) 519-524
11. Neri T.M., Cavestro G.M., Seghini P., Zanelli P.F., Zanetti A., Savi M., et al. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis 35 (2003) 571-576
12. Norris S., Kondeatis E., Collins R., Satsangi J., Clare M., Chapman R., et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 120 (2001) 1475-1482
13. Wiencke K., Spurkland A., Schrumpf E., and Boberg K.M. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34 (2001) 625-630
14. Mitchell S.A., Grove J., Spurkland A., Boberg K.M., Fleming K.A., Day C.P., et al. Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 49 (2001) 288-294
15. Bernal W., Moloney M., Underhill J., and Donaldson P.T. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 30 (1999) 237-241
16. Karlsen T.H., Boberg K.M., Olsson M., Sun J.Y., Senitzer D., Bergquist A., et al. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 46 (2007) 899-906
17. Heath S.C., Gut I.G., Brennan P., McKay J.D., Bencko V., Fabianova E., et al. Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet 16 (2008) 1413-1429
18. Sollid L.M., and Thorsby E. The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 36 (1990) 136-137
19. Chapman R.W., Arborgh B.A., Rhodes J.M., Summerfield J.A., Dick R., Scheuer P.J., et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21 (1980) 870-877
20. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201-214
21. Robinson J., Waller M.J., Parham P., de Groot N., Bontrop R., Kennedy L.J., et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 31 (2003) 311-314
22. Donaldson P.T., Farrant J.M., Wilkinson M.L., Hayllar K., Portmann B.C., and Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 13 (1991) 129-133
23. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
24. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
25. Tiwari J.L., and Terasaki P.I. The data and statistical analysis. HLA and disease associations (1985), Springer-Verlag, New York p. 18-27
26. Doherty D.G., and O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 174 (2000) 5-20
27. Hata K., Van Thiel D.H., Herberman R.B., and Whiteside T.L. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 15 (1992) 816-823
28. Hashimoto E., Lindor K.D., Homburger H.A., Dickson E.R., Czaja A.J., Wiesner R.H., et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 68 (1993) 1049-1055
29. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
30. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., and Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173 (2004) 4273-4276
31. Lorentzen A.R., Karlsen T.H., Olsson M., Smestad C., Mero I.L., Woldseth B., et al. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol 65 (2009) 658-666
32. Ahlenstiel G., Martin M.P., Gao X., Carrington M., and Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118 (2008) 1017-1026
33. Hanvesakul R., Spencer N., Cook M., Gunson B., Hathaway M., Brown R., et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 8 (2008) 1931-1941
34. Nejentsev S., Howson J.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 (2007) 887-892
35. Gaudieri S., Kulski J.K., Dawkins R.L., and Gojobori T. Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res 9 (1999) 541-549
36. van Bergen J., Thompson A., van der Slik A., Ottenhoff T.H., Gussekloo J., and Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 173 (2004) 6719-6726
37. Kapp J.A., Kapp L.M., and McKenna K.C. Gammadelta T cells play an essential role in several forms of tolerance. Immunol Res 29 (2004) 93-102
38. Martins E.B., Graham A.K., Chapman R.W., and Fleming K.A. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 23 (1996) 988-993
39. Ponsioen C.Y., Kuiper H., Ten Kate F.J., de Wit M., van Deventer S.J., and Tytgat G.N. Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 11 (1999) 769-774
40. Melum E., Karlsen T.H., Schrumpf E., Bergquist A., Thorsby E., Boberg K.M., et al. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology 47 (2008) 90-96
41. Price P., Witt C., Allcock R., Sayer D., Garlepp M., and Kok C.C. Et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 167 (1999) 257-274
42. Guinan K.J., Cunningham R.T., Meenagh A., Dring M.M., Middleton D., and Gardiner C.M. Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun 1 (2010) 67-78
43. Okolicsanyi L., Fabris L., Viaggi S., Carulli N., Podda M., and Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 8 (1996) 685-691
44. Gaya D.R., Russell R.K., Nimmo E.R., and Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 (2006) 1271-1284
45. Escorsell A., Pares A., Rodes J., Solis-Herruzo J.A., Miras M., and De la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol 21 (1994) 787-791
46. Colhoun H.M., McKeigue P.M., and Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 (2003) 865-872